Back to Search Start Over

A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme

Authors :
Charlotte Demoor-Goldschmidt
Delphine Drui
Isabelle Doutriaux
Gérard Michel
Pascal Auquier
Agnès Dumas
Claire Berger
Valérie Bernier
Sandrine Bohrer
Pierre-Yves Bondiau
Bruno Filhon
Brice Fresneau
Claire Freycon
Dinu Stefan
Sylvie Helfre
Angela Jackson
Christine Kerr
Anne Laprie
Julie Leseur
Marc-André Mahé
Caroline Oudot
Claire Pluchard
Stéphanie Proust
Hélène Sudour-Bonnange
Céline Vigneron
Nathalie Lassau
Martin Schlumberger
Cécile Faure Conter
Florent de Vathaire
Source :
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Publication Year :
2017
Publisher :
BMC, 2017.

Abstract

Abstract Background Survival of childhood, adolescent and young adult (CAYA) cancers has increased with progress in the management of the treatments and has reached more than 80% at 5 years. Nevertheless, these survivors are at great risk of second cancers and non-malignant co-morbidities in later life. DeNaCaPST is a non-interventional study whose aim is to organize a national screening for thyroid cancer and breast cancer in survivors of CAYA cancers. It will study the compliance with international recommendations, with the aim, regarding a breast screening programme, of offering for every woman living in France, at equal risk, an equal screening. Method DeNaCaPST trial is coordinated by the INSERM 1018 unit in cooperation with the LEA (French Childhood Cancer Survivor Study for Leukaemia) study’s coordinators, the long term follow up committee and the paediatric radiation committee of the SFCE (French Society of Childhood Cancers). A total of 35 centres spread across metropolitan France and la Reunion will participate. FCCSS (French Childhood Cancer Survivor Study), LEA and central registry will be interrogated to identify eligible patients. To participate, centers agreed to perform a complete “long-term follow-up consultations” according to good clinical practice and the guidelines of the SFCE (French Society of Children Cancers). Discussion As survival has greatly improved in childhood cancers, detection of therapy-related malignancies has become a priority even if new radiation techniques will lead to better protection for organs at risk. International guidelines have been put in place because of the evidence for increased lifetime risk of breast and thyroid cancer. DeNaCaPST is based on these international recommendations but it is important to recognize that they are based on expert consensus opinion and are supported by neither nonrandomized observational studies nor prospective randomized trials in this specific population. Over-diagnosis is a phenomenon inherent in any screening program and therefore such programs must be evaluated.

Details

Language :
English
ISSN :
14712407
Volume :
17
Issue :
1
Database :
Directory of Open Access Journals
Journal :
BMC Cancer
Publication Type :
Academic Journal
Accession number :
edsdoj.34085dd954d319dcb4e39a7891721
Document Type :
article
Full Text :
https://doi.org/10.1186/s12885-017-3318-1